Health Matters: FDA links weight-loss drug to cancer
The Federal Drug Administration recalled prescription weight-loss drug Belviq because it's been linked to cancer.
The generic name for the drug is Lorcaserin.
The FDA started taking a close look at it last month.
Clinical trials showed people who take it could end up getting cancer.
Thursday the FDA asked the company to take it off the market.